Generalized Anxiety Disorder: all 518 studies

Page 5 of 6. Open to participants first (125), then studies with results posted, then the rest; newest registration first within each.

• Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled TrialCompletedNCT02219880Phase 4
• Youth Mayo Clinic Anxiety Coach Randomized Controlled TrialCompletedNCT02205203Not applicable
• Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community ClinicsCompletedNCT02150265Not applicable
• Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia NervosaCompletedNCT02148042
• A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation TherapyCompletedNCT02096484Not applicable
• False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety DisordersCompletedNCT02082561Not applicable
• Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to MenWithdrawnNCT02072252Phase 1/2
• Brief Behavioral Treatment for Anxiety in Young ChildrenCompletedNCT02051192Phase 1/2
• Microtuning a Bonafide Treatment for GAD Patients - A Randomized Controlled Trial.CompletedNCT02039193Phase 4
• Training Protocol 'Drop it'. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in RemissionCompletedNCT01983033Not applicable
• Attention Bias Modification Treatment for Anxious YouthTerminatedNCT01979263Not applicable
• Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other ComorbitiesCompletedNCT01975480Phase 4
• Desvenlafaxine Monotherapy in DysthymiaCompletedNCT01948895Not applicable
• At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
• Attention Retraining for Anxiety Disorder Patients Resistent to AntidepressantsStatus unknownNCT01906268Not applicable
• Treating Emotional Disorders in Primary Care With Psychological TechniquesCompletedNCT01903096Phase 4
• Study Of Remission In Patients Treated For Generalized Anxiety DisorderCompletedNCT01788553
• Calmer Life: Testing the Effectiveness of a Treatment for AnxietyCompletedNCT01702220Not applicable
• Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in ChildrenStatus unknownNCT01687764Not applicable
• Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety DisorderCompletedNCT01681329Not applicable
• Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety DisorderCompletedNCT01614041Phase 4
• Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)CompletedNCT01607710
• Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy ControlsStatus unknownNCT01570426
• Internet-based Treatment of Generalized Anxiety DisorderCompletedNCT01570374Not applicable
• Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum DisordersCompletedNCT01565629Not applicable
• Bringing What Works to Youth in Corrections: A Trauma InterventionCompletedNCT01560728Phase 1/2
• Evaluation of Generalization Paradigm Patterns Among Different Psychiatric DisordersStatus unknownNCT01501812
• Treatment Study for Rural Latino Youth With AnxietyCompletedNCT01491880Phase 1/2
• Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety DisorderCompletedNCT01488799Not applicable
• Online Treatments for Mood and Anxiety Disorders in Primary CareCompletedNCT01482806Phase 2/3
• PHARMO Institute Seroquel Safety StudyCompletedNCT01342120
• Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD)CompletedNCT01337713Not applicable
• Psychodynamic Internet Treatment Versus Cognitive Behavioral Therapy (CBT) for Generalized Anxiety DisorderCompletedNCT01312116Not applicable
• A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety DisorderCompletedNCT01311180Phase 2
• Electronic Self-management Resource Training for Mental HealthCompletedNCT01304862Not applicable
• Cipralex® for Anxiety Disorders in AdolescentsStatus unknownNCT01293838Phase 1
• The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage FormCompletedNCT01285115Phase 3
• Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety DisordersCompletedNCT01243606Not applicable
• Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical SectorCompletedNCT01203293Phase 1
• Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and AdolescentsCompletedNCT01160588
• Stress Reduction and Anxiety: Effects on the Function and Structure of the BrainCompletedNCT01128309Not applicable
• Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed ProfessionalsActive, not recruitingNCT01075672Not applicable
• Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD)Status unknownNCT01032473
• RCT of an Acceptance-based Behavior Therapy for GADCompletedNCT00961493Not applicable
• Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety DisorderCompletedNCT00951652Not applicable
• Desensitization and Cognitive Therapy in General Anxiety.CompletedNCT00951340Phase 1
• Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study)CompletedNCT00947570Not applicable
• Treatment of Late-life Anxiety in Primary Care SettingsCompletedNCT00938093Not applicable
• A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety DisorderCompletedNCT00921063Phase 2
• Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety DisorderTerminatedNCT00836069Phase 3
• A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy SubjectsWithdrawnNCT00820794Phase 1
• Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same TimeTerminatedNCT00809536Phase 1
• Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The BodyTerminatedNCT00800280Phase 1
• Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety DisorderCompletedNCT00788034Phase 3
• Sleep, Mood, and Behavior StudyCompletedNCT00787397Not applicable
• Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment StudyCompletedNCT00774150Not applicable
• Assessing Different Methods of Anxiety Care in Pediatric SettingsWithdrawnNCT00769925Not applicable
• Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary CareCompletedNCT00765219Not applicable
• 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)WithdrawnNCT00738738Phase 3
• Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in NorwayCompletedNCT00735995Phase 2
• A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)TerminatedNCT00735267Phase 3
• Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety DisorderCompletedNCT00715039Not applicable
• Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six MonthsCompletedNCT00711737
• A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)CompletedNCT00703833Phase 2
• Quetiapine in Co-Morbid Depressive and Anxiety DisordersCompletedNCT00688818Not applicable
• Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD)CompletedNCT00662584Phase 3
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)TerminatedNCT00658762Phase 3
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)TerminatedNCT00658372Phase 3
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)TerminatedNCT00658008Phase 3
• Chamomile Therapy for Generalized AnxietyCompletedNCT00645983Phase 4
• rTMS Treatment in Patients With General Anxiety DisorderCompletedNCT00616447Not applicable
• ERP N1 as a Treatment Predictor of Generalized Anxiety DisorderCompletedNCT00613067Not applicable
• Attention Training for Generalized Anxiety DisorderCompletedNCT00602563Not applicable
• Virtual Reality as Anxiety Management Tool for Generalized Anxiety DisorderCompletedNCT00602212Not applicable
• Comorbidity Between Balance and Childhood AnxietyStatus unknownNCT00599742Not applicable
• Effects of Parental Behavior on Child Anxiety RegulationCompletedNCT00593515Phase 2
• Effectiveness Study of CBT for Anxiety in ChildrenCompletedNCT00586586Phase 2
• Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School SettingsCompletedNCT00569829Phase 2
• A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety DisorderCompletedNCT00542685Phase 3
• Treatment of Patients With Anxiety Disorder (0777-022)CompletedNCT00539578Phase 2
• A Pilot Study of Cranial Electrotherapy Stimulation[CES] for Generalized Anxiety DisorderCompletedNCT00539357Phase 4
• An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male VolunteersCompletedNCT00537615Phase 1
• Evaluating the Effects of Stress in PregnancyCompletedNCT00525226
• Therapeutic Massage for Generalized Anxiety DisorderCompletedNCT00515242Phase 1/2
• Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI StudyTerminatedNCT00491348Not applicable
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety DisorderCompletedNCT00481325Phase 2/3
• Efficacy of Treatment for Generalized Anxiety DisorderCompletedNCT00456742
• Aripiprazole for the Treatment of Refractory AnxietyCompletedNCT00438386Phase 4
• Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GADCompletedNCT00426426Not applicable
• An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderCompletedNCT00417118Phase 3
• An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety DisorderCompletedNCT00390533Phase 3
• Trial of Seroquel SR for Alcohol Dependence and Comorbid AnxietyCompletedNCT00352469Phase 4
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderCompletedNCT00329446Phase 3
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety DisorderCompletedNCT00329264Phase 3
• Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety DisorderCompletedNCT00322595Phase 3
• Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.CompletedNCT00314210Phase 3
• Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary CareCompletedNCT00308724Not applicable
• Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety DisorderCompletedNCT00277654Phase 3
• A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCompletedNCT00236067Phase 3
• A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCompletedNCT00236054Phase 3

← Generalized Anxiety Disorder overview